PixarBio Corp PXRB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- — / —
- Market Cap
- $80.21
- Volume/Avg
- 100 / 100
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 1
- Website
- https://www.pixarbio.com
Valuation
Metric
|
PXRB
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
PXRB
|
---|---|
Quick Ratio | 0.73 |
Current Ratio | 0.73 |
Interest Coverage | — |
Quick Ratio
PXRB
Profitability
Metric
|
PXRB
|
---|---|
Return on Assets (Normalized) | −43.27% |
Return on Equity (Normalized) | −59.53% |
Return on Invested Capital (Normalized) | −59.53% |
Return on Assets
PXRB
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Dhjskpzslk | Ycsz | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Trnmwvlg | Mpnjj | $103.6 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Wncpqhwnj | Gfqjdxq | $97.8 Bil | |
MRNA
| Moderna Inc | Lhrkjxbt | Hgld | $38.8 Bil | |
ARGX
| argenx SE ADR | Kllsrkxv | Lvpb | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Dyvdnvrf | Zbbg | $21.2 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Hlkdbknj | Rrxckx | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Blflttck | Kbpbwm | $17.3 Bil | |
RPRX
| Royalty Pharma PLC Class A | Wfvsdjcg | Hcvvqs | $12.5 Bil | |
INCY
| Incyte Corp | Cbfgcnpt | Dlzszb | $11.5 Bil |